Induction of immunological tolerance to islet allografts

Cell Transplantation

Volumn 5, Issue 1, 1996, Pages 49-52

  Rossini, A A ^a   Parker, D C ^a   Phillips, N E ^a   Durie, F H ^a   Noelle, R J ^a   Mordes, J P ^a   Greiner, D L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Allograft; CD40; CD40 ligand; Islet; Tolerance

Indexed keywords

CD40 ANTIGEN; GLUCOSE; GLYCOPROTEIN GP 39; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MR1; PROTEIN ANTIBODY; STREPTOZOCIN; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DEPLETION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SPLEEN LYMPHOCYTE; STREPTOZOCIN DIABETES; T LYMPHOCYTE;

EID: 0029919866     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/0963-6897(95)02010-1     Document Type: Article

References (28)

1. A. Aruffo M. Farrington D. Hollenbaugh X. Li A. Milatovich S. Nonoyama The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome Cell 72 1993 291 300
2. J.E. Buhlmann T.M. Foy A. Aruffo K.M. Crassi J.A. Ledbetter W.R. Green the absence of a CD40 signal, B cells are tolerogenic Immunity 2 1995 1 20
3. F.H. Durie R.A. Fava T.M. Foy A. Aruffo J.A. Ledbetter R.J. Noelle Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40 Science 261 1993 1328 1330
4. E.E. Eynon D.C. Parker Small B cells as antigenpresenting cells in the induction of tolerance to soluble protein antigens J. Exp. Med. 175 1992 131 138
5. E.E. Eynon D.C. Parker Parameters of tolerance induction by antigen targeted to B lymphocytes J. Immunol. 151 1993 2958 2964
6. T.M. Foy D.M. Shepherd F.H. Durie A. Aruffo J.A. Ledbetter R.J. Noelle In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 J. Exp. Med. 178 1993 1567 1575
7. E.J. Fuchs P. Matzinger B cells turn off virgin but not memory T cells Science 258 1992 1156 1159
8. K.M. Gilbert W.O. Weigle Tolerogenicity of resting and activated B cells J. Exp. Med. 179 1994 249 258
9. P.A. Gottlieb J.P. Berrios G. Mariani E.S. Handler D. Greiner J.P. Mordes Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats Diabetes 39 1990 643 645
10. S. Hori S. Sato S. Kitagawa T. Azuma S. Kokudo T. Hamaoka Tolerance induction of allo-class H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft J. Immunol. 143 1989 1447 1452
11. K.J. Lafferty S.J. Prowse C.J. Simeonovic H.S. Warren Immunobiology of tissue transplantation: A return to the passenger leukocyte concept Annu. Rev. Immunol. 1 1983 143 173
12. H. Lau K. Reemtsma M.A. Hardy Pancreatic islet allograft prolongation by donor-specific blood transfusions treated with ultraviolet irradiation Science 221 1983 754 756
13. D.J. Lenschow Y. Zeng J.R. Thistlethwaite A. Montag W. Brady M.G. Gibson Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g Science 257 1992 789 792
14. H. Lin S.F. Bolling P.S. Linsley R.-Q. Wei D. Gordon C.B. Thompson Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA41g plus donor-specific transfusion J. Exp. Med. 178 1993 1801 1806
15. Y. Liu C.A. Janeway Jr. Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells 2nd ed. Proc. Natl. Acad. Sci. USA 89 1992 3845 3849
16. C.E. Morrow D.E.R. Sutherland M.W. Steffes J.S. Najarian F.H. Bach H-2 antigen class: Effect on mouse islet allograft rejection Science 219 1983 1337 1339
17. R.J. Noelle J.A. Ledbetter A. Aruffo CD40 and its ligand, an essential ligand-receptor pair for thymusdependent B-cell activation Immunol. Today 13 1992 431 433
18. R.J. Noelle M. Roy D.M. Shepherd I. Stamenkovic J.A. Ledbetter A. Aruffo A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells 2nd ed. Proc. Natl. Acad. Sci. USA 89 1992 6550 6554
19. D.C. Parker T cell-dependent B cell activation Annu. Rev. Immunol. 11 1993 331 360
20. D.C. Parker E.E. Eynon Antigen presentation in acquired immunological tolerance FASEB J. 5 1991 2777 2784
21. D.C. Parker D.L. Greiner N.E. Phillips M.C. Appel A.W. Steele F.H. Durie Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand 2nd ed. Proc. Natl. Acad. Sci. USA 96 1995 9560 9564
22. E.A. Ranheim T.J. Kipps Activated T cells induce expression of B7/BB 1 on normal or leukemic B cells through a CD40-dependent signal J. Exp. Med. 177 1993 925 935
23. R.H. Schwartz A cell culture model for T lymphocyte clonal anergy Science 248 1990 1349 1356
24. M.K. Spriggs R.J. Armitage L. Strockbine K.N. Clifford B.M. Macduff T.A. Sato Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion J. Exp. Med. 176 1992 1543 1550
25. P. Tan C. Anasetti J.A. Hansen J. Melrose M. Brunvand J. Bradshaw Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB 1 J. Exp. Med. 177 1993 165 173
26. C.B. Thompson T. Lindsten J.A. Ledbetter S.L. Kunkel H.A. Young S.G. Emerson CD28 activation pathway regulates the production of multiple T-cell derived lymphokines/cytokines 2nd ed. Proc. Natl. Acad. Sci. USA 86 1989 1333 1337
27. E. Van Twuyver R.J.D. Mooijaart I.J.M. Ten Berge A.R. Van der Horst J.M. Wilmink W.M. Kast Pretransplantation blood transfusion revisited N. Engl. J. Med. 325 1991 1210 1213
28. B.J. Whalen H.P. Tony D.C. Parker Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by la-restricted Th2 helper T cell lines J. Immunol. 141 1988 2230 2239